November 6, 2014
by Ethan Huff, Health Journalist
(AlignLife.com) Ebola vaccines are being sped to market with the endorsement of the United Nations, and large supplies should be ready for use on West Africans in 2015, according to reports from Agence France-Presse. However, this vaccine is untested and experimental, bypassing the normal testing and approval process that usually vets a new vaccine. Sound like the “swine flu” all over again?
One vaccine, manufactured by British drug giant GlaxoSmithKline (GSK), (the company associated with the largest drug fraud settlement in history), and another manufactured by U.S.-based NewLink Genetics, are being accelerated through clinical trials, says the World Health Organization (WHO) Assistant Director General Marie-Paule Kieny. If all goes as planned, shots of the vaccine will be available to health workers by the end of this year.
“If everything goes well, we may be able to begin using some of these vaccines in some of the affected countries at the very beginning of next year,” stated Kieny to the media.
Expect 10,000 doses to be ready for Christmas
[Silver Bulletin Sponsor Links: EBOLA Protocol, Vaccine Protocol]